Showing results (191-200 of 377) with videos related to
Sort By:
Pageof 38
JNCI Cancer Spectrum|July 16, 2019
Randomized Noninferiority Trial of Telephone vs In-Person Genetic Counseling for Hereditary Breast and Ovarian Cancer: A 12-Month Follow-UpMary K Interrante, Hannah Segal, Beth N Peshkin, et al.Radiology|July 21, 2007
Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening studyConstance D Lehman, Claudine Isaacs, Mitchell D Schnall, et al.Breast (Edinburgh, Scotland)|June 15, 2010
Alcohol consumption and the risk of breast cancer among BRCA1 and BRCA2 mutation carriersJessica Dennis, Parviz Ghadirian, Julian Little, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2024
First-in-Human Dose-Escalation Study of Fianlimab, an Antilymphocyte Activation Gene-3 Antibody, with Cemiplimab in Patients with Advanced MalignanciesNehal J Lakhani, Kyriakos P Papadopoulos, Melissa Lynne Johnson, et al.European Journal of Cancer (Oxford, England : 1990)|November 1, 2024
Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort studyCarmine Valenza, Dario Trapani, Paola Zagami, et al.The Lancet. Oncology|March 3, 2006
Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort studySusan M Domchek, Tara M Friebel, Susan L Neuhausen, et al.Journal of Oncology Practice|August 28, 2014
Preliminary Development and Evaluation of an Algorithm to Identify Breast Cancer Chemotherapy Toxicities Using Electronic Medical Records and Administrative DataJeanne S Mandelblatt, Karl Huang, Solomon B Makgoeng, et al.Translational Behavioral Medicine|November 13, 2018
Predictors of risk-reducing surgery intentions following genetic counseling for hereditary breast and ovarian cancerMary Kathleen Ladd, Beth N Peshkin, Leigha Senter, et al.Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|February 13, 2009
Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfactionMarc D Schwartz, Heiddis B Valdimarsdottir, Tiffani A DeMarco, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2008
Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study GroupKelly A Metcalfe, Jan Lubinski, Parviz Ghadirian, et al.Pageof 38